Validation that metabolic tumor volume predicts outcome in head-and-neck cancer. - Wikidata - wikimedia - TriplyDB

Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.

Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.

http://www.wikidata.org/entity/Q35916573

about

Prognostic value of FDG PET imaging in patients with laryngeal cancer.Metabolic Tumor Volume Measured by F-18 FDG PET/CT can Further Stratify the Prognosis of Patients with Stage IV Non-Small Cell Lung Cancer.Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer.Metabolic tumour volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgery Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.Volumetric PET/CT parameters predict local response of head and neck squamous cell carcinoma to chemoradiotherapy FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma.Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma Predictive and prognostic value of metabolic tumor volume (MTV) in patients with laryngeal carcinoma treated by radiotherapy (RT) / concurrent chemoradiotherapy (CCRT)Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522.FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose posit [18F]Fluorodeoxyglucose uptake by positron emission tomography predicts outcomes for oropharyngeal and hypopharyngeal cancer treated with definitive radiotherapy.Application of fluorodeoxyglucose positron emission tomography in the management of head and neck cancers.The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer.Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.A review of the predictive role of functional imaging in patients with mucosal primary head and neck cancer treated with radiation therapy.Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.18F-FDG PET-CT performed before and during radiation therapy of head and neck squamous cell carcinoma: Are they independent or complementary to each other?Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.Anal cancer FDG-PET standard uptake value: correlation with tumor characteristics, treatment response and survival.Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.Prognostic value of (18)F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma.Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters.Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristics.Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma.Prognostic value of midtreatment FDG-PET in oropharyngeal cancer.Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer.Prognostic value of volumetric FDG PET/CT parameters in patients with oral tongue squamous cell carcinoma who were treated by superselective intra-arterial chemoradiotherapy.Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours.SUVmax on FDG-PET is a predictor of prognosis in patients with maxillary sinus cancer.Prognostic significance of metabolic tumor volume in patients with piriform sinus carcinoma treated by radiotherapy with or without concurrent chemotherapy.Influence of volumetric 4'-[methyl-11C]-thiothymidine PET/CT parameters for prediction of the clinical outcome of head and neck cancer patients.Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status.

P2860

Q33599739-BEAA4CA4-FD09-4E3A-98D7-0EE8F0C239ED Q33704656-43F72A23-D27F-449D-ADE3-09F0B91D1555 Q33863850-858C554A-87A9-4023-8865-76BC8222AE55 Q34346395-0C976F41-CF90-4725-A2F5-2E4F8BAFDE08 Q34757933-109C3ED6-9A37-4A0B-BD20-C0427EACB39D Q34998582-E94470DC-F504-452D-8A46-182DA8A42BD0 Q35096160-B97195FE-6019-4CC4-A417-182283ED64E9 Q35096212-462B13F5-5330-4ED5-9C27-D54E4DDC6D53 Q35102986-F439C90C-14BE-4372-B8B4-100436258F55 Q36355220-048212C9-51DC-4E54-811E-1C594667F640 Q36655475-A141FEBF-5950-422F-A10E-80F27BCA2CB2 Q37192658-06377E64-25AA-45A7-9B50-E516BD355B87 Q37694583-D40B4CEE-E74E-4B58-9842-139131942F07 Q38224477-FBF66E67-D528-4C58-B0D3-2DBF88371018 Q38478344-E321C4AA-EB72-423D-AA4C-92AA72D0DA51 Q38599041-23F12DB9-E9FC-4536-A63E-FA93857F59E7 Q38617866-E9B49CC6-071A-42F3-96F7-56A24147313F Q38836743-17775DA5-D6E1-4A2D-80F6-127FB9D6C3D2 Q38896865-ED654367-A463-452A-94D4-EBCB25F027AF Q38909224-8B639F5B-AB55-4E12-AE8A-28CD432C5500 Q40187157-277989C6-26EC-40A4-B27F-E3EE6519401A Q40780999-CFB14CF6-2A5A-404B-B733-EACC7D3A1B57 Q40890024-6BAAE017-25CA-466C-B805-81B5D9FA53E8 Q41685883-519DC91C-46AA-4485-ABCB-7371C588426B Q41957872-65186AFD-83B6-48B0-9D2B-EB8EE8FA6E3A Q45371931-5CD7B99C-E187-40D0-B8DB-208BAA08D252 Q45947136-31ED68A7-3FA8-4D49-9767-0FAE6A02EE2C Q46284024-DE9228FA-A8EC-45F5-92AD-3D7A2C8078CD Q46627197-C4015719-E163-40A8-B395-B70C708BF8F8 Q47429122-FE62F01B-A6ED-4721-A439-82BD7EF76F43 Q48177211-6B9204B9-4245-48D3-BF78-6308F8943975 Q49147470-6AE13672-A775-4C3E-A47F-09D1FBEA4294 Q50875336-4631D2CB-B104-4434-8D3B-970662709955 Q52968001-175472FF-F2BA-4B72-89BB-BDE399036C13 Q52970700-A1688210-7C9A-40F9-A8AC-0C9DECD184A9 Q53063987-31814B68-64E2-4B19-8248-C8C554C9B678

P2860

Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.

http://www.wikidata.org/entity/Q35916573

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.

@ast

Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.

@en

type

label

Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.

@ast

Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.

@en

prefLabel

Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.

@ast

Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.

@en

P1433

Q35916573-45D5D34C-8CEF-43D9-A108-D5CD3CDD6FFB

P1476

Q35916573-F56965BB-6E17-4D7B-8D1A-43A9FFF6880E

P2093

Q35916573-2138B729-3497-4C3C-93FB-563D357D7010

Q35916573-32B52824-E644-4916-8B71-8D1CF28DFEAA

Q35916573-54244B04-FCF0-434F-B664-6D088E6A6D1B

Q35916573-66710B73-73B8-428C-B41E-6DB42ADD2487

Q35916573-7274F67F-2AB7-4BDD-AA77-6D786B2239F7

Q35916573-7E091FEF-21CF-4866-8C43-38119F8A1A83

Q35916573-98965CF2-8EBA-4B26-A31A-C2848E7816B4

Q35916573-A5349626-6B74-4489-AD08-A6C6CDAA1B60

Q35916573-AE0B4C72-E692-4E05-9342-38B3C618EE58

Q35916573-AFCA94BE-CC9E-4DD7-A629-08551BEACE13

P2860

Q35916573-109F8433-0552-4231-B8E5-D2803BEC799C

Q35916573-25430464-7913-4DDC-870C-352D9F8051EC

Q35916573-3700B338-944F-439C-A462-DECF9B9CF3E0

Q35916573-3C494CFF-BE35-4C8A-ACD3-01EAC116701D

Q35916573-41BDC3D1-BD5A-4C96-9745-E3D35BDAB1B9

Q35916573-57595DDE-111A-414C-BC38-C6EBBE5B839E

Q35916573-59148068-4E77-4759-8894-CABA9CC5C190

Q35916573-5C6BEC6E-E459-46BB-9EC0-04AB86136CB7

Q35916573-6B96628F-C091-46A4-BDAF-661F937DE6F6

Q35916573-882CEB53-C616-470D-A5E7-AE551F829B99

P304

Q35916573-91DB130E-5E9E-46A5-BE31-FE17A34726E6

P31

Q35916573-85755F23-D6D8-42A8-8315-3C14264D2190

P356

Q35916573-EDCA4FD2-DB24-4B09-A74D-3B121D42F3A8

P407

Q35916573-08026801-A606-4D17-821D-8FEAB644D516

P433

Q35916573-6F26306B-F8AF-48BB-91B5-C50611F16839

P478

Q35916573-DBC164C7-1921-4785-B279-2EB8A93681EA

P577

Q35916573-95F33DE4-D531-42B9-AAB6-B941A4290A10

P698

Q35916573-4C746DC4-E7BC-4416-A5D5-18BF8C5E365C

P932

Q35916573-6F102C92-C30D-47DE-815A-4B6FF53E2B6F

P356

J.IJROBP.2011.10.023

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.

@en

P2093

A Dimitrios Colevas

http://www.w3.org/2001/XMLSchema#string

Andrei H Iagaru

http://www.w3.org/2001/XMLSchema#string

Billy W Loo

http://www.w3.org/2001/XMLSchema#string

Brian Khong

http://www.w3.org/2001/XMLSchema#string

Chad Tang

http://www.w3.org/2001/XMLSchema#string

Christina Kong

http://www.w3.org/2001/XMLSchema#string

Edward E Graves

http://www.w3.org/2001/XMLSchema#string

James D Murphy

http://www.w3.org/2001/XMLSchema#string

Nancy J Fischbein

http://www.w3.org/2001/XMLSchema#string

Quynh-Thu Le

http://www.w3.org/2001/XMLSchema#string

P2860

Human papillomavirus and survival of patients with oropharyngeal cancer.

HPV-associated head and neck cancer: a virus-related cancer epidemic.

Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.

Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer

Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure.

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.

Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.

The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas.

Platelet and endothelial adhesion on fluorosurfactant polymers designed for vascular graft modification

P304

1514-1520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2011.10.023

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22270174

http://www.w3.org/2001/XMLSchema#string

P932

3337958

http://www.w3.org/2001/XMLSchema#string